1. Home
  2. RNAZ vs UPC Comparison

RNAZ vs UPC Comparison

Compare RNAZ & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$3.38

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Logo Universe Pharmaceuticals Inc.

UPC

Universe Pharmaceuticals Inc.

N/A

Current Price

$5.85

Market Cap

3.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RNAZ
UPC
Founded
2016
1998
Country
United States
China
Employees
12
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
RNAZ
UPC
Price
$3.38
$5.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.3K
791.7K
Earning Date
04-15-2026
01-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.30
$2.00
52 Week High
$20.99
$17.96

Technical Indicators

Market Signals
Indicator
RNAZ
UPC
Relative Strength Index (RSI) 29.42 54.41
Support Level N/A $2.87
Resistance Level $6.15 $7.20
Average True Range (ATR) 0.50 0.97
MACD -0.18 0.10
Stochastic Oscillator 3.58 51.59

Price Performance

Historical Comparison
RNAZ
UPC

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Share on Social Networks: